Endocrinology, Vol 132, 1381-1386, Copyright © 1993 by Endocrine Society

ARTICLES

Oxytocin receptor subtypes in the pregnant rat myometrium and decidua: pharmacological differentiations

WY Chan, DL Chen and M Manning
Department of Pharmacology, Cornell University Medical College, New York, New York 10021.

Oxytocin (OT) has a dual action in the uterus: a uterotonic action on myometrial cells and a prostaglandin (PG)-releasing action on endometrial/decidual cells. It had not been determined whether the OT- binding sites or receptors on the myometrial and the endometrial/decidual membranes are of the same type or may represent two subtypes. Our studies presented in this paper show that isolated day 19-22 pregnant rat uterine horns and myometrial tissues (uterine horns with decidual tissues removed) incubated in Kreb's buffer at 37 C released PGF2 alpha in sustained quantities into the bathing medium. OT stimulated PG release over the basal release rate in a dose-dependent manner in the whole uterine horn but not in the myometrial tissue. Two OT antagonists, P[Phe(Me)2,Thr4]ornithine vasotocin (antagonist A) and desGly-NH2(9),d(CH2)5(1)[Tyr(Me)2,Thr4]ornithine vasotocin (antagonist B) were found to have different effects on the PG-releasing action of OT. At antiuterotonic doses, antagonist A had no antagonism of the PG- releasing action of OT. On the contrary, antagonist A was found to stimulate uterine PG release. Antagonist B was a full OT antagonist. At equivalent antiuterotonic doses, antagonist B inhibited both the uterotonic action and the PG-releasing action of OT. These findings suggest that OT-sensitive PGs are synthesized/released principally in the endometrium/decidua. The myometrial uterotonic OT receptors and the endometrial/decidual PG-releasing OT receptors are two distinct subtypes and can be differentiated. The existence of two OT receptor subtypes in the uterus has important implications in the clinical application of OT antagonists as tocolytics for preterm labor. To be efficacious, OT antagonist therapy needs to block both the uterotonic and the PG-releasing action of OT.

This article has been cited by other articles:

				A. Benoussaidh, Y. Maurin, and O. Rampin Possible neural mediation of the central effects of oxytocin on uterine motility Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R798 - R804. [Abstract] [Full Text] [PDF]

				G. Gimpl and F. Fahrenholz The Oxytocin Receptor System: Structure, Function, and Regulation Physiol Rev, April 1, 2001; 81(2): 629 - 683. [Abstract] [Full Text] [PDF]

				A. M. Mackler, C. A. Ducsay, J. D. Veldhuis, and S. M. Yellon Maturation of Spontaneous and Agonist-Induced Uterine Contractions in the Peripartum Mouse Uterus Biol Reprod, October 1, 1999; 61(4): 873 - 878. [Abstract] [Full Text]

				M. Thibonnier, D. M. Conarty, J. A. Preston, C. L. Plesnicher, R. A. Dweik, and S. C. Erzurum Human Vascular Endothelial Cells Express Oxytocin Receptors Endocrinology, March 1, 1999; 140(3): 1301 - 1309. [Abstract] [Full Text]

				J. Gutkowska, M. Jankowski, C. Lambert, S. Mukaddam-Daher, H. H. Zingg, and S. M. McCann Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart PNAS, October 14, 1997; 94(21): 11704 - 11709. [Abstract] [Full Text] [PDF]

				J. J. Evans, W. Forrest-Owen, and C. A. McArdle Oxytocin Receptor-Mediated Activation of Phosphoinositidase C and Elevation of Cytosolic Calcium in the Gonadotrope-Derived {alpha}T3-1 Cell Line Endocrinology, May 1, 1997; 138(5): 2049 - 2055. [Abstract] [Full Text] [PDF]

				Wen Wu and P. W. Nathanlelsz Changes in Oxytocin Receptor Messenger RNA in the Endometrium, Myometrium, Mesometrium, and Cervix of Sheep in Late Gestation and During Spontaneous and Cortisol-Induced Labor Reproductive Sciences, July 1, 1994; 1(3): 191 - 196. [Abstract] [PDF]